SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

Tivantinib®: MET receptor and HGF ligand 

Prev Next
Previous

Pexelizumab® Series: 2

medical illustration of PowerPoint images and design for pharmaceutical method-of-action of Tivantinib, designed to block the activity of a molecule known as c-Met that plays multiple key roles in human cancer.
Next medical illustration of Part of  series of method of action graphics for pharmaceutical project

Early Atherosclerotic Lesion

PowerPoint images and design for pharmaceutical method-of-action of Tivantinib, designed to block the activity of a molecule known as c-Met that plays multiple key roles in human cancer.

Keywords: Airbrush, Color, Design, Information Graphics, Education, Allergy / Immunology, Biology, Biotechnology, Cell biology / Histology, Disease Management, Endocrinology / Metabolic, Molecular Biology, Pharmacology

© Mica Duran